These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6388921)
1. Does insulin administration contribute to immune complex formation in diabetes? Campbell LV; Charlesworth JA; Pasterfield GV; Jenkins A; Pussell BA Clin Exp Immunol; 1984 Nov; 58(2):255-63. PubMed ID: 6388921 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827 [TBL] [Abstract][Full Text] [Related]
3. Significance of circulating immune complexes in pulmonary tuberculosis. Samuel AM; Ashtekar MD; Ganatra RD Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714 [TBL] [Abstract][Full Text] [Related]
4. Soluble LDL-immune complexes in type 2 diabetes and vascular disease. Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029 [TBL] [Abstract][Full Text] [Related]
5. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin. Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926 [TBL] [Abstract][Full Text] [Related]
6. [HLA typing and insulin antibody production in insulin-dependent diabetics]. Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704 [TBL] [Abstract][Full Text] [Related]
7. [Preliminary note on anti-insulin antibody formation in diabetics treated with porcine insulin]. Bchir F; Boujaafar N; Ben Salem M; Achour A Arch Inst Pasteur Tunis; 1984 Mar; 61(1):1-8. PubMed ID: 6398991 [TBL] [Abstract][Full Text] [Related]
8. Cellular immune alterations associated with human insulin therapy. Eichner HL; Lauritano AA; Woertz LL; Selam JL; Gupta S; Charles MA Diabetes Res; 1988 Jul; 8(3):111-5. PubMed ID: 3067952 [TBL] [Abstract][Full Text] [Related]
9. [Disorders of the hormonal and immune status of patients with newly detected diabetes mellitus]. Dubrovskaia GV; Malyzhev VA; Sakalo EA Vrach Delo; 1989 Aug; (8):58-60. PubMed ID: 2588531 [TBL] [Abstract][Full Text] [Related]
10. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]. Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124 [No Abstract] [Full Text] [Related]
11. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes]. Bruni KB; Neirotti R; Albonico G; Gamba S; Regis G; D'Adda A; Soldano E; Bruni B Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349 [TBL] [Abstract][Full Text] [Related]
12. [Immune complexes in diabetes mellitus]. Kocić R; Radenković S; Milenović M; Mijailović M; Koraćević G; Zivić S; Pesić M; Kosić G Srp Arh Celok Lek; 1994; 122 Suppl 1():60-3. PubMed ID: 18173190 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients. Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468 [TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038 [TBL] [Abstract][Full Text] [Related]
15. RIA measurement of insulin antibodies in human sera using the polyethyleneglycol separation technique. Simionescu L; Oprescu M; Mirodon Z Endocrinologie; 1979; 17(3):191-5. PubMed ID: 504959 [TBL] [Abstract][Full Text] [Related]
16. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
17. Identification of components of IC purified from human sera. I. Immune complexes purified from sera of patients with SLE. Maire MA; Barnet M; Carpentier N; Miescher PA; Lambert PH Clin Exp Immunol; 1983 Feb; 51(2):215-24. PubMed ID: 6839539 [TBL] [Abstract][Full Text] [Related]
18. Insulin antibody production studied quantitatively with a modified radioimmunoassay technique and with radioimmunoelectrophoresis in patients treated with monocomponent (MC) insulin. Bruni B; Ricci C; Giolitti A; Osenda M; D'Alberto M; Turco GL J Nucl Biol Med; 1973; 17(3):123. PubMed ID: 4746315 [No Abstract] [Full Text] [Related]
19. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Henricsson M; Nilsson A; Janzon L; Groop L Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089 [TBL] [Abstract][Full Text] [Related]
20. Analysis of IgA1 and IgA2 subclass distribution in IgA- containing circulating immune complexes in patients with diabetes mellitus. Triolo G; Giardina E; Seddio G; Terrizzi C Boll Ist Sieroter Milan; 1987; 66(2):116-9. PubMed ID: 3311077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]